Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Voyager Therapeut (VYGR)

Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 221,844
  • Shares Outstanding, K 55,600
  • Annual Sales, $ 80,000 K
  • Annual Income, $ -65,000 K
  • EBIT $ -140 M
  • EBITDA $ -143 M
  • 60-Month Beta 1.23
  • Price/Sales 2.93
  • Price/Cash Flow N/A
  • Price/Book 1.06

Options Overview Details

View History
  • Implied Volatility 500.24% (+144.49%)
  • Historical Volatility 57.74%
  • IV Percentile 91%
  • IV Rank 63.93%
  • IV High 751.22% on 11/10/25
  • IV Low 55.31% on 01/21/25
  • Expected Move (DTE 22) 0.43 (10.44%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 8
  • Volume Avg (30-Day) 25
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 6,314
  • Open Int (30-Day) 6,384
  • Expected Range 3.65 to 4.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.54
  • Number of Estimates 6
  • High Estimate -0.41
  • Low Estimate -0.72
  • Prior Year -0.59
  • Growth Rate Est. (year over year) +8.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.73 +8.97%
on 12/02/25
4.58 -11.14%
on 12/16/25
-0.03 (-0.73%)
since 11/24/25
3-Month
3.73 +8.97%
on 12/02/25
5.55 -26.67%
on 10/16/25
-0.18 (-4.24%)
since 09/24/25
52-Week
2.64 +53.88%
on 05/30/25
6.27 -35.09%
on 01/07/25
-1.71 (-29.58%)
since 12/24/24

Most Recent Stories

More News
Voyager Therapeutics: Q3 Earnings Snapshot

Voyager Therapeutics: Q3 Earnings Snapshot

VYGR : 4.07 (+2.01%)
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia

CAMBRIDGE, United Kingdom and LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Transition Bio, a drug discovery company focused on unlocking traditionally “undruggable” targets by leveraging biomolecular...

VYGR : 4.07 (+2.01%)
Voyager Reports Third Quarter 2025 Financial and Operating Results

- Momentum building around tau: expect VY7523 clinical data and VY1706 clinical entry in 2026 -  - Sharpened focus on multi-modality pipeline with introduction of Voyager NeuroShuttle™ discovery...

VYGR : 4.07 (+2.01%)
Voyager Therapeutics (VYGR) Receives a Buy from Oppenheimer

Oppenheimer analyst Jay Olson maintained a Buy rating on Voyager Therapeutics today and set a price target of $18.00. The company’s shares closed yesterday at $4.68.Elevate Your Investing Strategy: Take...

VYGR : 4.07 (+2.01%)
Voyager to Present at Upcoming Investor Conferences

LEXINGTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced...

VYGR : 4.07 (+2.01%)
Voyager Therapeutics: Q2 Earnings Snapshot

Voyager Therapeutics: Q2 Earnings Snapshot

VYGR : 4.07 (+2.01%)
Voyager Reports Second Quarter 2025 Financial and Operating Results

- Cash runway extended into 2028; expected to enable multiple meaningful clinical data read-outs - - APOE program added to pipeline; fourth asset in industry-leading Alzheimer’s disease franchise...

VYGR : 4.07 (+2.01%)
Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach

- New program combines IV-delivered TRACER™ capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager’s...

VYGR : 4.07 (+2.01%)
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

VYGR : 4.07 (+2.01%)
Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication

VYGR : 4.07 (+2.01%)

Business Summary

Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease and preclinical programs...

See More

Key Turning Points

3rd Resistance Point 4.27
2nd Resistance Point 4.18
1st Resistance Point 4.12
Last Price 4.07
1st Support Level 3.97
2nd Support Level 3.88
3rd Support Level 3.82

See More

52-Week High 6.27
Fibonacci 61.8% 4.89
Fibonacci 50% 4.46
Last Price 4.07
Fibonacci 38.2% 4.03
52-Week Low 2.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar